The role of early life genistein exposures in modifying breast cancer risk

Br J Cancer. 2008 May 6;98(9):1485-93. doi: 10.1038/sj.bjc.6604321. Epub 2008 Apr 8.


Review of the existing literature suggests that consumption of soy foods or an exposure to a soy isoflavone genistein during childhood and adolescence in women, and before puberty onset in animals, reduces later mammary cancer risk. In animal studies, an exposure that is limited to the fetal period or adult life does not appear to have the same protective effect. A meta-analysis of human studies indicates a modest reduction in pre- and postmenopausal risk when dietary intakes are assessed during adult life. These findings concur with emerging evidence indicating that timing may be vitally important in determining the effects of various dietary exposures on the susceptibility to develop breast cancer. In this review, we address the mechanisms that might mediate the effects of an early life exposure to genistein on the mammary gland. The focus is on changes in gene expression, such as those involving BRCA1 and PTEN. It will be debated whether mammary stem cells are the targets of genistein-induced alterations and also whether the alterations are epigenetic. We propose that the effects on mammary gland morphology and signalling pathways induced by pubertal exposure to genistein mimic those induced by the oestrogenic environment of early first pregnancy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anticarcinogenic Agents / pharmacology*
  • Apoptosis / drug effects
  • BRCA1 Protein / genetics
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Cell Proliferation / drug effects
  • Disease Susceptibility
  • Epigenesis, Genetic
  • Female
  • Gene Expression / drug effects
  • Genes, Tumor Suppressor / drug effects
  • Genistein / pharmacology*
  • Humans
  • Mutation / drug effects
  • PTEN Phosphohydrolase / genetics
  • Phytoestrogens / pharmacology*
  • Puberty
  • Risk Assessment
  • Sexual Maturation
  • Soy Foods*
  • Time Factors
  • Up-Regulation / drug effects


  • Anticarcinogenic Agents
  • BRCA1 Protein
  • Phytoestrogens
  • Genistein
  • PTEN Phosphohydrolase
  • PTEN protein, human